- Home
- DXPE vs VCEL Comparison
DXPE vs VCEL Comparison
Compare DXPE & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXPE
- VCEL
- Stock Information
- Founded
- DXPE 1908
- VCEL 1989
- Country
- DXPE United States
- VCEL United States
- Employees
- DXPE N/A
- VCEL N/A
- Industry
- DXPE Industrial Machinery/Components
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DXPE Industrials
- VCEL Health Care
- Exchange
- DXPE Nasdaq
- VCEL Nasdaq
- Market Cap
- DXPE 1.9B
- VCEL 1.8B
- IPO Year
- DXPE 1996
- VCEL 1997
- Fundamental
- Price
- DXPE $100.33
- VCEL $40.96
- Analyst Decision
- DXPE Buy
- VCEL Strong Buy
- Analyst Count
- DXPE 1
- VCEL 6
- Target Price
- DXPE $95.00
- VCEL $60.40
- AVG Volume (30 Days)
- DXPE 151.9K
- VCEL 659.8K
- Earning Date
- DXPE 11-06-2025
- VCEL 11-06-2025
- Dividend Yield
- DXPE N/A
- VCEL N/A
- EPS Growth
- DXPE 36.17
- VCEL 236.54
- EPS
- DXPE 5.27
- VCEL 0.25
- Revenue
- DXPE $1,959,889,000.00
- VCEL $258,716,999.00
- Revenue This Year
- DXPE $10.99
- VCEL $18.35
- Revenue Next Year
- DXPE $6.65
- VCEL $22.26
- P/E Ratio
- DXPE $18.97
- VCEL $163.78
- Revenue Growth
- DXPE 12.76
- VCEL 14.05
- 52 Week Low
- DXPE $67.31
- VCEL $29.24
- 52 Week High
- DXPE $130.97
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- DXPE 33.00
- VCEL 67.48
- Support Level
- DXPE $96.60
- VCEL $37.84
- Resistance Level
- DXPE $106.00
- VCEL $43.00
- Average True Range (ATR)
- DXPE 5.54
- VCEL 1.80
- MACD
- DXPE -2.49
- VCEL 0.45
- Stochastic Oscillator
- DXPE 17.21
- VCEL 71.85
About DXPE DXP Enterprises Inc.
DXP Enterprises Inc is a distributor of products and services to industrial customers in the United States, Canada, Mexico, and Dubai. The company's reportable segments include Service Centers, Innovative Pumping Solutions, and Supply Chain Services. It generates maximum revenue from the Service Centers segment. The company offers pumping solutions, supply chain services and maintenance, repair, operating, and production services for rotating equipment, bearings, power transmissions, industrial supplies, and safety products. It serves the General Industrial, Oil & Gas, Food & Beverage, Water & Wastewater, Chemical, Transportation, Aerospace & Others.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.